SERVIMED SAS

What SERVIMED SAS does

SERVIMED S.A.S. is a private Colombian healthcare services provider (Sociedad por Acciones Simplificada) founded in 2002 in Bucaramanga, Santander, operating as an Institución Prestadora de Servicios de Salud (IPS) under the legal name SERVIMED S.A.S. The company delivers two integrated service lines: specialized rheumatology consultations covering conditions such as rheumatoid arthritis, lupus, osteoarthritis, Sjögren's syndrome, psoriatic arthritis, gout, dermatomyositis, ankylosing spondylitis, and migraine, and a clinical research center that conducts Phase II/III clinical trials in rheumatology and autoimmune diseases for global pharmaceutical sponsors and CROs.

The underlying operating model rests on INVIMA certification in Good Clinical Practices (granted April 8, 2011, twice renewed) and ISO 9001:2015 certification from ICONTEC (Certificate SC-2000273, December 2022), both of which are required to credibly serve as a clinical trial site in Colombia. Operations are concentrated in a single facility at Calle 51 No. 34-17, Consultorios 201, 205 y 208, C.C. Cabecera Primera Etapa, Bucaramanga, with an 11-person team. Patient acquisition is driven by referral agreements (convenios) with multiple Colombian EPS health insurance providers, supplemented by direct appointment scheduling via WhatsApp and an Instagram presence (@servimed_sas).

The business generates revenue from two streams: (1) professional services fees from rheumatology consultations billed through EPS agreements, and (2) clinical research contracts with global sponsors including Merck Sharp y Dohme (MSD), Novartis, IQVIA, and historically Kendle, which compensate the site per protocol. Documented sponsor recognitions span 2007–2021 (Kendle best recruiters in Colombia for Lupus, MSD best deadline adherence 2012, Novartis best recruitment 2014, IQVIA contribution 2021), evidencing a 14+ year operational track record in clinical research. The company's stated vision targets consolidation by 2026 as a referral center for clinical studies in different research phases for new drug development in rheumatology.

Name

SERVIMED SAS

Legal name

SERVIMED S.A.S.

Website

https://servimed.net.co

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

SERVIMED S.A.S. is a Colombian healthcare IPS in Bucaramanga that delivers specialized rheumatology consultations and operates an INVIMA-certified clinical research center conducting Phase II/III trials for global pharmaceutical sponsors.

Ownership category

akta.pro rank

Product category

Specialty Healthcare Services - Rheumatology and Clinical Research

NAICS

Offices of Physicians (except Mental Health Specialists) (621111), Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Autoimmune/Immune Dysregulation Specialty Clinics (HLAKAAAJ)

akta.pro secondary industries

Rheumatology Telemedicine Platforms (HLALAGAG), Autoimmune & Allergy Diagnostics (HLAAALAK)

Keywords

• Rheumatology consultations
• Clinical trial services
• Autoimmune disease treatment
• Pharmaceutical research site
• Specialty healthcare services

Headquarters

HQ city

Bucaramanga

HQ country

Colombia

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Healthcare Consultation Services: SERVIMED SAS generates revenue through specialized rheumatology consultations and clinical research services. The organization provides healthcare services to patients and conducts clinical trials sponsored by pharmaceutical companies and CROs, which likely serve as a primary revenue stream.
2. Clinical Research Services: SERVIMED conducts clinical trials for pharmaceutical companies including Merck Sharp y Dohme, MSD, Novartis, and IQVIA, receiving compensation for research activities.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

SERVIMED S.A.S. delivers specialized rheumatology consultation services for the early diagnosis and treatment of rheumatic and autoimmune diseases, and operates a Clinical Research Center that conducts clinical trials of new therapeutic molecules in rheumatology. Services target patients with conditions such as rheumatoid arthritis, lupus, osteoarthritis, Sjögren's syndrome, psoriatic arthritis, gout, dermatomyositis, ankylosing spondylitis, and migraine, with research sponsored by pharmaceutical companies and CROs.

Product overview

SERVIMED SAS is a healthcare company offering two integrated core services: specialized rheumatology consultation (Servicios de Reumatología) providing comprehensive diagnosis and treatment for rheumatic diseases, and a Clinical Research Center (Estudios Clínicos) conducting clinical trials for new therapeutic molecules. The rheumatology service serves patients with conditions including arthritis, lupus, and autoimmune diseases, while the clinical studies program enables patient participation in research to advance medical treatments.

Differentiator

Problem solved

Functional benefit

Products and services

• Servicios de Reumatología (Rheumatology Services) Specialized rheumatology consultation program providing early diagnosis and timely treatment for rheumatic and autoimmune diseases, including rheumatoid arthritis, lupus (SLE), osteoarthritis, Sjögren's syndrome, psoriatic arthritis, gout, dermatomyositis, ankylosing spondylitis, and migraine. Services are delivered to individual patients at the Bucaramanga facility, with referrals accepted through EPS health insurance partners.
• Estudios Clínicos (Clinical Research Center) Clinical Research Center conducting clinical trials of new therapeutic molecules in rheumatology for pharmaceutical sponsors and CROs (including MSD, Novartis, IQVIA, and Kendle). Covers indications such as Lupus (SLE), Lupus Nephritis, Rheumatoid Arthritis, Sjögren's Syndrome, and other rheumatic conditions, with over 14 years of accumulated trial experience and INVIMA Good Clinical Practices certification.

Quantifiable outcome

• Over 14 years of clinical trial experience in rheumatology

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core.

• Fundación Cardiovascular de Colombia - Comité de ÉticacoreStrategic or Co-development Partner · 1 November 2005In November 2005, SERVIMED constituted its Ethics Committee in Investigations as a response to Good Clinical Practice guidelines, with the Fundación Cardiovascular de Colombia's ethics committee serving as the monitoring entity for their first clinical trial on osteoarthritis.
• Kendle (Organization by Contract)coreStrategic or Co-development PartnerIn 2007, SERVIMED researchers were recognized by Kendle as the best recruiters in Colombia for Systemic Lupus Erythematosus studies.
• Merck Sharp y Dohme (MSD)coreStrategic or Co-development PartnerPharmaceutical sponsor that has provided study recognition to SERVIMED for clinical trial performance in MK0822-018 study, with 2012 recognition for best deadline adherence.
• NovartiscoreStrategic or Co-development PartnerPharmaceutical sponsor for AIN457A2302 (secukinumab) study, with May 2014 recognition for good recruitment performance.
• IQVIAcoreStrategic or Co-development PartnerContract Research Organization (CRO) sponsor for CAIN457P12302 and CAIN457P12301 studies, with 2021 recognition for study performance and contribution.
• EPS Entities (Colombian Health Insurance Providers)coreChannel Partner/ Reseller/ DistributorSERVIMED has agreements (convenios) with multiple Colombian health insurance providers (EPS) for the referral and provision of rheumatology services to their affiliated patients. Logos of collaborating EPS partners are displayed on their services page.

Scale indicators4 records

Recent moves7 records

Expansion highlights3 records

Broad incumbents

• Syneos Health: Large CRO with biopharmaceutical services and clinical research site operations. Comparable as a clinical research services provider operating in rheumatology/autoimmune trials similar to SERVIMED's portfolio.
• IQVIA Holdings: World's largest CRO and an active sponsor of SERVIMED trials (CAIN457P12301/02). Comparable as a clinical research services provider; IQVIA is the global incumbent while SERVIMED operates as a regional specialty site feeding into its study pipeline.
• ICON plc: Major global CRO with significant Latin America clinical trial operations. Directly comparable as a clinical research site network operator and competing for the same pharma-sponsored rheumatology/autoimmune trial placements.
• Charles River Laboratories: Global clinical research and preclinical services organization. Comparable in operating a clinical research services business addressing pharma sponsors in similar therapeutic indications as SERVIMED's portfolio.

Direct peers

• Parexel International: Global CRO with deep rheumatology and autoimmune therapeutic experience. Comparable as a clinical research services firm operating investigator sites and managing pharma-sponsored trials similar to those SERVIMED conducts.
• Medpace Holdings: Mid-sized global CRO with growing Latin America presence. Comparable in operating model as a clinical research services firm competing for sponsor study allocation in rheumatology and autoimmune indications.
• Worldwide Clinical Trials: Mid-sized global CRO with active Latin America site network. Directly comparable as a clinical research organization competing for autoimmune and rheumatology trial placements with experienced investigator sites.

Regional players

• Centro Médico Imbanaco: High-complexity Colombian specialty clinic and clinical research site in Cali. Comparable as a regional Colombian specialty healthcare provider with EPS affiliations and active participation in sponsored clinical trials.
• Fundación Cardiovascular de Colombia: Major Colombian healthcare and research institution in Santander that has served as SERVIMED's ethics committee partner since 2005. Directly comparable as a regional Colombian clinical research and specialty healthcare provider operating in the same geography.
• Hospital Pablo Tobón Uribe: Large Colombian academic hospital with active clinical research programs and EPS partnerships. Comparable as a Colombian healthcare provider operating an investigator site network for pharma-sponsored trials in similar therapeutic areas.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/servimed_sas/?igsh=MWtuajkwYTNndDViag%3D%3D
• LinkedInlinkedin.com/company/servimedsas

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SERVIMED SAS